UMIN-CTR History

Name：　　UMIN ID：

Unique ID issued by UMIN	UMIN000014873
Receipt number	R000016811
Scientific Title	Phase1/2 study of nab-Paclitaxel + trastuzumab therapy in 2nd line treatment for HER2-positive advanced or recurrent gastric cancer refractory to trastuzumab combined with fluoropyrimidine and platinum.
Date of disclosure of the study information	2014/09/01
Last modified on	2018/09/10 18:11:58

---